Xlife Sciences AG (CHIX:XLSZ) Short-Term Debt : CHF5.25 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Xlife Sciences AG Short-Term Debt?

Xlife Sciences AG's Short-Term Debt for the quarter that ended in Dec. 2024 was CHF5.25 Mil.

Xlife Sciences AG's quarterly Short-Term Debt increased from Dec. 2023 (CHF0.84 Mil) to Jun. 2024 (CHF2.12 Mil) and increased from Jun. 2024 (CHF2.12 Mil) to Dec. 2024 (CHF5.25 Mil).

Xlife Sciences AG's annual Short-Term Debt increased from Dec. 2022 (CHF0.00 Mil) to Dec. 2023 (CHF0.84 Mil) and increased from Dec. 2023 (CHF0.84 Mil) to Dec. 2024 (CHF5.25 Mil).

Xlife Sciences AG Short-Term Debt Historical Data

The historical data trend for Xlife Sciences AG's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG Short-Term Debt Chart

Xlife Sciences AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

0.84

5.25

Xlife Sciences AG Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Debt	Get a 7-Day Free Trial								-	-	0.84	2.12	5.25

Xlife Sciences AG Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Xlife Sciences AG Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (CHIX:XLSz) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

XLS:Switzerland

Address

Talacker 35, Zurich, CHE, 8001

Website

https://www.xlifesciences.ch

Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.

Xlife Sciences AG Headlines

No Headlines